What is the main business of Riget Investment?

The main business activity of Riget Investment focuses on other monetary intermediation.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 4, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Żelazna 59, 00-848 Warszawa.

Who is on the management board?

The management board consists of: Adam Becmer (President of the Management Board) and Sebastian Konrad Nowocin (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 200,000 (approx. $54,025).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

Riget Investmentsp. z o.o.

Other monetary intermediation

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-01-04

Share capital

200 000,00 PLN

Activity description

Riget Investment is a company that develops software for healthcare entities, with its flagship product being PACJENT+, a comprehensive tool for managing small, medium, and large clinics. It offers services such as electronic medical documentation, integration with medical devices, and financial settlements with the National Health Fund (NFZ) and insurance companies. Additionally, it provides professional maintenance and advisory services tailored to the needs of healthcare providers.

Registered address

ul. Żelazna 59/203, 00-848 Warszawa, Poland

Website

riget.pl

Phone

Social media

Electronic delivery address

AE:PL-45632-27455-IAVFJ-26

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

News

2023-12-19

Version 4.38.6 Released

2023-12-08

Version 4.38.4 Released

2023-11-01

Version 4.38.3 Released

2023-09-13

Version 4.38.2 Released

2023-09-11

Version 4.38.1 Released

2023-08-31

Version 4.37.2 Released

Industry

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
May 25, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Stołecznego Warszawy

Tenders

No recorded participation in tenders.

Authorized Representatives

Adam Becmer — President of the Management Board

Sebastian Konrad Nowocin — Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Adam Becmer (46)	2,000	$27,012.43	50%
Sebastian Konrad Nowocin (45)	2,000	$27,012.43	50%

Beneficial owners

Person	Rights
Adam Becmer (46)	Shareholder of a limited liability company, 100000.0 PLN
Sebastian Konrad Nowocin (45)	Shareholder of a limited liability company, 100000.0 PLN

Competitors

Name	Revenue	Website
LM PayS.A.	$7,041,862.81	mediraty.pl
Unity Caresp. z o.o.	$1,172,733.13	unitycare.pl
EndofundS.A.	$670,573.41	endofund.pl
Investment & Intermediationsp. z o.o.	$179,984.09	intermediation.pl
G3 Medical HoldingS.A.	$79,789.06	g3medical.pl

FAQ

Last updated: 2026-07-04